Stefan Josef Hammerschmidt (Stefan J Hammerschmidt)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Molecular Docking

Atomic Force Microscopy

Respiratory Syndrome Coronavirus

Top Venues

International journal of molecular sciences

Communications chemistry

RSC medicinal chemistry

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Francisco Javier Medrano, Sergio de la Hoz-Rodríguez, Sergio Martí, Kemel Arafet, Tanja Schirmeister, Stefan Josef Hammerschmidt, Christin Müller, Águeda González-Martínez, Elena Santillana, John Ziebuhr, Antonio Romero, Collin Zimmer, Annabelle Carolin Weldert, Robert Zimmermann, Alessio Lodola, Katarzyna Świderek, Vicent Moliner, Florenci V González
Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. Communications chemistry 7 (1) (2024)
Francisco Javier Medrano, Sergio de la Hoz-Rodríguez, Sergio Martí, Kemel Arafet, Tanja Schirmeister, Stefan Josef Hammerschmidt, Christin Müller, Águeda González-Martínez, Elena Santillana, John Ziebuhr, Antonio Romero, Collin Zimmer, Annabelle Carolin Weldert, Robert Zimmermann, Alessio Lodola, Katarzyna Świderek, Vicent Moliner, Florenci V González
Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2. Communications chemistry 7 (1) (2024)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)
Gabriella B Souza, Larissa Sens, Stefan Josef Hammerschmidt, Natália F de Sousa, Maryelle A G de Carvalho, Carlos V D Dos Santos, Tiago Tizziani, Monalisa A Moreira, Luiz A E Pollo, Erlon F Martin, Jose S S Neto, Maique Weber Biavatti, Francisco F de Assis, Bonaventure Tchaleu Ngadjui, Ingrid Simo Konga, Pantaléon Ambassa, Marcus Tullius Scotti, Luciana Scotti, Antonio Luiz Braga, Tanja Schirmeister, Louis Pergaud Sandjo
Inhibitory effects of 190 compounds against SARS-CoV-2 M pr o protein: Molecular docking interactions. Archiv der Pharmazie (2023)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V González, Bernd Engels, Tanja Schirmeister
Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors-A Comprehensive Reactivity and Selectivity Study. International journal of molecular sciences 24 (8) (2023)
Stefan Josef Hammerschmidt, Hannah Maus, Annabelle Carolin Weldert, Michael Gütschow, Christian Kersten
Improving binding entropy by higher ligand symmetry? - A case study with human matriptase. RSC medicinal chemistry 14 (5) (2023)